E-Cadherin Is Expressed by Mono- and Multinucleated Histiocytes in Cutaneous Sarcoidal and Foreign Body Granulomas

被引:15
作者
Wanat, Karolyn A. [1 ]
Rosenbach, Misha [1 ]
Zoiber, Amy F. [2 ]
Zhang, Paul J. [2 ]
Schaffer, Andras [1 ]
机构
[1] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
E-cadherin; granuloma; histiocyte; multinucleated giant cells; sarcoidosis; foreign body; IN-VIVO; CELLS; MICE;
D O I
10.1097/DAD.0b013e31828de7e0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
E-cadherin, a member of the cadherin family of transmembrane adhesion receptors, is critical for cutaneous barrier function, as it promotes keratinocyte and Langerhans cell adhesion in the epidermis. Recent murine models of chronic inflammation identified new E-cadherin expressing subsets of mononuclear phagocytes, including alternatively activated macrophages and selected inflammatory dendritic cells. It has been shown in vitro that expression of E-cadherin by murine macrophages promotes their homotypic aggregation and fusion to multinucleated giant cells (MNGCs), a signature cell type of granulomatous inflammation. The purpose of this study was to assess E-cadherin expression on histiocytes and giant cells in cutaneous granulomas in humans. E-cadherin expression was evaluated by immunohistochemistry of formalin-fixed paraffin-embedded skin biopsies of foreign body granulomas (n = 21) and sarcoidosis (n = 21). The results showed consistent membranous E-cadherin staining pattern on mononucleated histiocytes and MNGCs in both granuloma types. These E-cadherin expressing histiocytes are distinct from dermal Langerhans cells because they lacked CD1a expression. Our findings suggest that E-cadherin expressing mononuclear histiocytes are likely precursors for MNGCs in cutaneous granulomas and may play a critical role in disease pathogenesis.
引用
收藏
页码:651 / 654
页数:4
相关论文
共 19 条
[1]
Bergeron A, 1997, J IMMUNOL, V159, P3034
[2]
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice [J].
Biedermann, T ;
Zimmermann, S ;
Himmelrich, H ;
Gumy, A ;
Egeter, A ;
Sakrauski, AK ;
Seegmüller, I ;
Voigt, H ;
Launois, P ;
Levine, AD ;
Wagner, H ;
Heeg, K ;
Louis, JA ;
Röcken, M .
NATURE IMMUNOLOGY, 2001, 2 (11) :1054-1060
[3]
BOROS DL, 2003, CELLULAR IMMUNOLOGIC, P1
[4]
Alternatively activated dendritic cells regulate CD4+ T-cell polarization in vitro and in vivo [J].
Cook, Peter C. ;
Jones, Lucy H. ;
Jenkins, Stephen J. ;
Wynn, Thomas A. ;
Allen, Judith E. ;
MacDonald, Andrew S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (25) :9977-9982
[5]
Langerhans cell histiocytosis reveals a new IL-17A dependent pathway of dendritic cell fusion [J].
Coury, Fabienne ;
Annels, Nicola ;
Rivollier, Aymeric ;
Olsson, Selma ;
Santoro, Alessandra ;
Speziani, Carole ;
Azocar, Olga ;
Flacher, Monique ;
Djebali, Sophia ;
Tebib, Jacques ;
Brytting, Maria ;
Egeler, R. Maarten ;
Rabourdin-Combe, Chantal ;
Henter, Jan-Inge ;
Arico, Maurizio ;
Delprat, Christine .
NATURE MEDICINE, 2008, 14 (01) :81-87
[6]
Sarcoidosis is a Th1/Th17 multisystem disorder [J].
Facco, Monica ;
Cabrelle, Anna ;
Teramo, Antonella ;
Olivieri, Valeria ;
Gnoato, Marianna ;
Teolato, Sara ;
Ave, Elisa ;
Gattazzo, Cristina ;
Fadini, Gian Paolo ;
Calabrese, Fiorella ;
Semenzato, Gianpietro ;
Agostini, Carlo .
THORAX, 2011, 66 (02) :144-150
[7]
Monocyte and macrophage heterogeneity [J].
Gordon, S ;
Taylor, PR .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (12) :953-964
[8]
Alternative Activation of Macrophages: Mechanism and Functions [J].
Gordon, Siamon ;
Martinez, Fernando O. .
IMMUNITY, 2010, 32 (05) :593-604
[9]
Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules [J].
Helming, Laura ;
Gordon, Siamon .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (01) :33-42
[10]
Medical progress: Sarcoidosis [J].
Iannuzzi, Michael C. ;
Rybicki, Benjamin A. ;
Teirstein, Alvin S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2153-2165